As a stroke prevention device for patients with atrial fibrillation, the Amplatzer Amulet left atrial appendage (LAA) occluder is part of the industry-leading Amplatzer line of structural intervention occluders. The Amulet LAA Occluder is a part of Abbott’s broad structural heart portfolio.
Brand:
Share :
As a stroke prevention device for patients with atrial fibrillation, the Amplatzer Amulet left atrial appendage (LAA) occluder is part of the industry-leading Amplatzer line of structural intervention occluders. The Amulet LAA Occluder is a part of Abbott’s broad structural heart portfolio.
Percutaneous, catheter-based occlusion of the LAA—the therapy provided by the Amplatzer Amulet LAA Occluder—is an increasingly performed procedure aiming to reduce the risk of stroke in patients with nonvalvular atrial fibrillation.Current evidence suggests that transcatheter occlusion of the LAA reduces the risk of thromboembolic complications associated with nonvalvular atrial fibrillation.
